chrisvoncsefalvay/vaers-outcomes huggingface dataset:
loose stool; fever; chills; A spontaneous report was received from a consumer concerning a 87-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events fever, chills and loose stool.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 07 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 032M20A) Intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 08 Mar 2021, the patient experienced the event(s) fever, chills and loose stool.  Treatment details included pepto-bismol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), fever, chills and loose stool were unknown.
Pt has red circle about 5 inches in diameter around site of injection. pt has swollen lymph notes and the arm is hot to the touch
Baby woke at 11:45 PM screaming.  Went in, she felt very hot; inconsolable, wouldn't make eye contact, screaming.  Took temp in ear - 103.9.  Gave 0.8 mg Tylenol PO, called on-call physician, wiped baby down with cool washcloth.  Physician said to watch her for an hour to make sure fever went down.  Temp 100.6 at 12:30 AM.  Put her back to bed - slept until 7:15 AM.  Temp 99.4 in the morning.
The patient has been described as normally fussy after shots.  After vaccination she took a 2 hour nap and upon awakening cried for a total of 3 hours straight. She was better for about 4 hours and then had another 4 hour time period the next morning of prolonged crying.
Menstrual cycle disruption - the timing was appropriate, but the flow is heavier and lasting longer.
Received phone call from patient following high dose flu shot describing chills, coughing and red eyes (blood shot) approximately 4 to 5 hours after receiving flu shot. Later evening received another phone call from patient indicating some improvement of symptoms with less eye redness.
Friday evening developed rash on abdomen and arm. Vomited x 1, fever 101.
Pt called and reported raash all over back, shoulders, neck and went to dr and received rx for ZYRTEC and ZANTAC for hives (not life-threatening).
My daughter was given the first GARDASIL shot on Sept. 22, 2015 and one week later on Sept. 29, 2015 became sick. She was at school and had to have someone pick her up because she was very weak and felt like blacking out. We took her to the emergency room where she was put on IV meds to help control her heart rate that went over 150 3 or more times. She now has on a heart monitor and the Drs are leaning toward POTS. My child was healthy and active before I had her take this shot! I should have looked at all the warnings people have posted about GARDASIL.....I cannot believe the government can be so reckless with our children. I honestly felt that if the government allowed it and the Drs were encouraging it then everything should be fine. I took my "perfect" child and exposed her to possible HELL! I just pray she comes out of it.
MURDERED FOR 3 DAYS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced murdered for 3 days. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from murdered for 3 days. This report was non-serious. This case, involving the same patient is linked to 20220107322.
This spontaneous report was received from a licensed practical nurse, and refers to an unspecified numbers of patient of unknown age and gender. On unspecified dates since 01-MAR-2015, the unspecified number of patients were vaccinated with an improperly stored dose of GARDASIL lot # K023432, expiration date 18-JUN-2016 (strength, dose #, dose, route of administration and anatomical location were not provided). There was not concomitant medication reported. No adverse effects were reported. There was not a product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore left arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History Information was reported.     On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore left arm). On 31-Jan-2021, VACCINATION SITE PAIN (Sore left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    This case was linked to MOD21-035563 (E2B Linked Report). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 22-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore left arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History Information was reported.     On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore left arm). On 31-Jan-2021, VACCINATION SITE PAIN (Sore left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    This case was linked to MOD21-035563 (E2B Linked Report).; Sender's Comments:  MOD21-035563:
Mother of child reports the following event: red spots on trunk and arm pits, not itching, come and go. No change in behavior appetite or sleep. Spots are about 2" circular shape. Started when woke up next AM. Gone in evening, back next day etc.
vasovagal sycope , fainting , dizzy, started about  2 weeks after second shot
Developed a fine maculopapular rash all over body.   Also at the same time hemangioma on left cheek increased in size.
local inflammation & swelling of thigh, erythema & induration noted for 2 days;possible cellulitis;given med started on ATB;returned next day w/much improvement;
Erythema, swelling, rash slightly raised hot, tender to touch L thigh.
sweating; body aches; high fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), MYALGIA (body aches), PYREXIA (high fever) and CHILLS (chills) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Hysterectomy (Patient reported that she had a hysterectomy at 49 years old). Concurrent medical conditions included Cancer (Patient had been a cancer patient twice and was not taking any therapies at the time of the call for cancer).   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), MYALGIA (body aches), PYREXIA (high fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 15-Mar-2021, HYPERHIDROSIS (sweating), MYALGIA (body aches), PYREXIA (high fever) and CHILLS (chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   After 11 hours, patient had chills, body aches, and sweating due to a high fever for 48 hours. Concomitant medications was not provided by the reporter. Treatment information was not provided for all the other events.
resides in when on entire is a where 5 other residents on her floor have tested positive for COVID.  The past couple of days she has had worsening cough but has not had a significant shortness of breath.  Because of her symptoms she had a COVID swab done on 01/01 which was positive.  Because of her ongoing cough EMS was called.  She was placed on 10 L non-rebreather while in route to the emergency department.
fever 101, sore arm - couldn't lift arm at all , painful, muscle aches, diarrhea, sob, tachycardia/palpitations. diarrhea, nausea. symptoms started 5 hours after injection
Headache; Fever; Fatigue; Joint pain; Muscle pain; Nausea; This is a spontaneous report from a non-contactable pharmacist, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the right arm on 05Jun2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the right arm on 08May2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jun2021, the patient experienced headache, fever, fatigue, joint pain, muscle pain and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, fever, fatigue, joint pain, muscle pain and nausea was recovering at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 23-year-old male patient received BNT162b2 (BNT162B2), on 05May2022 as dose 4 (booster), single (Lot number: 017F21AFM9992) at the age of 23 years, in left arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history included: "Hydronephrosis" (unspecified if ongoing); "kidney stones" (unspecified if ongoing); "dairy" (unspecified if ongoing), notes: Reaction: Allergy: dairy. Concomitant medication(s) included: ALLEGRA, start date: 01Jan2015; LEXAPRO, start date: 01Aug2020; PRILOSEC [OMEPRAZOLE], start date: 01Jan2021; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, start date: 03May2022; TIVICAY, start date: 03May2022; also reported as patient received other medications in two weeks of starting COVID-19 treatment. Past drug history included: Nsaids, reaction(s): "NSAIDs: Drug Allergy"; Amoxicillin, reaction(s): "amoxicillin: Drug allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: negative for 8 days; Positive, notes: positive on Day 9. Therapeutic measures were taken as a result of drug ineffective, covid-19 included COVID 19 treatment started on 17May2022 and stopped on 22May2022. Clinical course was reported as, Paxlovid rebound. Tested positive on Day 9 after negative for 8 days, on 26May2022. No treatment received for symptoms and patient was recovering from symptoms.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.
Information has been received from a health professional concerning her niece who on 04JAN1999 was vaccinated with a dose of varicella virus vaccine live. It was reported that the child had a mild case of chicken pox break out. Unspecified medical attention was sought. The patient recovered. No product quality complaint was involved.  The patient's sister was also vaccinated with varicella virus vaccine live and got chicken pox and another patient was vaccinated with varicella virus vaccine live and got shingles. Additional information has been requested.  This is in follow up to report previously submitted on 05/14/2004, information has been received from a health professional concerning her 10 year old neice with no allergies or medical history who on 01/04/1999 was vaccinated SC in the left leg with a first dose of varicella virus vaccine live (lot 624724/1127E). There was no illness at the time of vaccination. Follow up information indicated that the child broke out with chicken pox on 01/28/2004. She was moderately covered with pox and was out of school for 1 week. There were no labs or diagnostic test done. She recovered fully on approximately 02/04/2004. The patients sister (WAES0403USA00669) was also vaccinated with varicella virus vaccine live (lot 624724/1127E) and got chicken pox and another patient (WAES0402USA01796) was vaccinated with varicella virus vaccine live (lot 624724/1327E) and got shingles. Additional information is not expected.
Hives over abdomen, chest.  Treatment with Benadryl elixir.
Vx was administered at approx. 10AM 7/31/18. When I arrived home at about 1PM I was surprised at how painful it was and took a single dose of 440 mg naprosyn. The next day (8/1/18) it was still painful but no medication was used. A 6AM on 8/2/18 the upper arm was swollen and erythematous. I also has mild flu-like symptoms and went to a walk-in clinic. At that time my blood pressure which had been 138/74 on 7/31 was in the high 160's to 180's. I have to attribute that to the vaccinal reaction as well as no alternate explanation is available. The area of redness and swelling was measured at 19cm x 19cm and was irregular in shape. At that visit there was very slight paresthesia in my forearm and hand. That has worsened since. For several hours after the walk-in visit the redness continued to spread but responded to icing the area and/or prescribed antihistamine. Redness has improved considerably but area is still edematous and painful and there is still significant numbness and tingling in my 4th and 5th digits. I communicated with Dr.s office yesterday by eMail as soon as I returned from the medical visit. I just confirmed that the eMail was received and opened. I've received no response of any kind.
Rash erupted on (R) upper thigh 10-11 days after vaccination; 5 maculopapular lesions on (R) upper thigh; non-vesicular; non-pruritic; mom states that 1% HC cream helps.
Received pneumonia vaccine 12-12-13 to (L) arm. Pain, swelling and redness started night of 12-13-13. Cannot lift arm or sleep due to pain and swelling. Area 4 x 6 inchs, redness and swelling to tricep muscle. Pt comes 3 days s/p pneumonia vaccine left tricept the lesion 10 cm diameter. Swelling began 1 day PRA. Area is tender to touch. No exudate. Skin is warm. Cellulitis 2nd to vaccination.
felt heated; uncomfortable; vomiting; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (felt heated), FEELING ABNORMAL (uncomfortable) and VOMITING (vomiting) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced FEELING HOT (felt heated), FEELING ABNORMAL (uncomfortable) and VOMITING (vomiting). At the time of the report, FEELING HOT (felt heated), FEELING ABNORMAL (uncomfortable) and VOMITING (vomiting) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   19-Apr-2021 The nurse practitioner at the clinic was on speaker phone with the patient and stated patient's skin was "warm and dry and the patient is feeling better now."  No concomitant medications were reported.
This spontaneous report as received from a pharmacist refers to unspecified patients of unknown demography. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with an expired dose of PNEUMOVAX 23 injection (strength, dose, route and lot number or batch number unspecified). No concomitant medications were reported. No adverse effect was reported. There were no product quality complaints (PQC) involved. No additional information was provided. Additional information is not expected, no contact details were provided.
Fall occurred, patient had trembling of both legs and arms, garbled speech for about an hour; couldn't walk without assistance for about 6 hours ,extreme fatigue for the next 48 hours and tiredness for the remainder of the week (3 days)
The Lot FL2757 expired 9/30/2022. No adverse reaction noted at clinic.
Immediate reaction (a couple hours) of fever, chills, confusion. Pt could not find door knob. Progressed to pt being admitted to ER (1-25-18).
Patient is a 77 y.o. male patient with history of DM, HTN, prostate ca, HLD presented to Hospital with weakness, who was found to have COVID-19.    Covid 19 virus infection Main symptom weakness, occasional dry cough Vitals stable, Currently on room air  CRP 31 CXR Persistent mild left basilar opacity may be due to scarring.  Mild atelectasis and/or a small left pleural effusion could also be present. Pneumonia is not suspected. PT/OT evaluated recommending home therapy, will also need tub seat prior to discharge  Social work consulted for assistance, however patient declining home health Being discharged with paxlovid, has four more doses left  Instructed to not take statin while on paxlovid  Tessalon as needed for cough    Hypertension Toprol dosing decreased from 200 to 100 mg daily while in the hospital  Will send in new prescription    Diabetes mellitus type 2 HgbA1c 7.1 Home metformin being held  Accu-Cheks with coverage Diabetic diet   HLD On rosuvastatin at home, currently on hold due being on paxlovid
no adverse event; an improperly dose of RECOMBIVAX HB was administered to a newborn; This spontaneous report as received from a healthcare professional refers to a "newborn" 1 day old female patient. On 19-JAN-2022, the patient was vaccinated with a 0.5 mL improperly dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (lot # T021327 exp date 14-NOV-2022) (dose and route not reported). The temperature of excursion was 49.9 F for a time frame of 2 hours 30 minutes. There was no previous temperature excursion or data logger issue.
Rash developed on my left arm, where I received my vaccination shot. The rash did not develop until a week later. Received the shot on 3/23 and did not notice the rash until 3/30, so not sure if this is related or not. I also developed a rash on my abdomen on 3/30, but not sure if this is related as well.
This report describes the occurrence of mercury poisoning in a male child of unspecified age who was vaccinated with hep B vaccine recombinant (Engerix B) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other healthcare professional. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received injections of Engerix B on 2/19/01 (lot 5168A2) and 1/29/02 (lot 5252A2). He also received injections of Tripedia 12/12/00 and 2/19/01 and Hib-Titer 10/10/00 and 12/12/00. The subject's attorney alleged that "As a result of the mercury in the Thimerosal-containing vaccinations that the subject received, he now suffers, and in the future will continue to suffer, from the toxic neurological effects of mercury poisoning." The attorney further alleged that the subject "has developed severe neurodevelopmental disorders with associated high mercury exposure levels as a result of the vaccinations he received, and has suffered serious permanent injury." Onset and treatment of the events were not specified. The mercury poisoning in this report, with resultant neurodevelopmental disorders, is considered medically serious (OMIC).
This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On 13-JUL-2016, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX (lot # M004662, expiry date 27-JAN-2018, dose, strength, vaccination site, route unspecified). The vaccine was exposed to a temperature of 6.5 Fahrenheit (F) for 80 hours. Digital data logger was not involved. There was no previous temperature excursions. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient complained of minor swelling and warmth in her left arm and some pain that radiated down to her elbow. This was reported at around 6 hours after the vaccine was administered. Told the patient that she could put some cold compresses over her arm and to take a benadryl to help reduce the swelling and motrin for the pain. If the swelling did not og down or was getting worse then she should go to the ER. Called patient on 10/12 at around 1 pm to check up on her and she was doing well. Patient said she went to the ER just in case the previous evening. physician gave her darvocet for the pain and that was all.
Extreme swelling, redness, itchiness on upper right arm at shot site.  The redness and swelling continued to grow for several days, completely covering my whole upper arm from the top of the deltoid muscle to the elbow all the the way around the arm.  Severe itching, swelling, redness, headaches, fatigue, and arm pain continued for over two weeks.  As of today (4/23/21), the site is still itchy with discoloration still visible and still feeling fatigued.
24 hours after 2nd HPV injection patient became ill with flu like symtoms, body aches, abdomial pain, decreased energy, generlly feeling unwell.
Sore throat, malaise, fever, cough, congestion;  given Tylenol 500mg, two tabs every 4-6 hrs.